Baird Financial Group
DGX icon

Baird Financial Group’s Quest Diagnostics DGX Stock Holding History

Baird Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.2M Sell
16,328
-62
-0.4% -$12K 0.01% 888
2025
Q4 		$2.84M Sell
16,390
-369
-2% -$67.2K ﹤0.01% 928
2025
Q3 		$3.19M Buy
16,759
+375
+2% +$66.5K 0.01% 887
2025
Q2 		$2.94M Sell
16,384
-1,571
-9% -$273K 0.01% 891
2025
Q1 		$3.04M Sell
17,955
-2,208
-11% -$363K 0.01% 834
2024
Q4 		$3.04M Sell
20,163
-267
-1% -$41.5K 0.01% 843
2024
Q3 		$3.17M Sell
20,430
-1,879
-8% -$281K 0.01% 822
2024
Q2 		$3.05M Sell
22,309
-84
-0.4% -$11.5K 0.01% 830
2024
Q1 		$2.98M Sell
22,393
-59,362
-73% -$7.7M 0.01% 832
2023
Q4 		$11.3M Sell
81,755
-2,639
-3% -$347K 0.03% 430
2023
Q3 		$10.3M Sell
84,394
-15,589
-16% -$2.08M 0.03% 419
2023
Q2 		$14.1M Buy
99,983
+62,441
+166% +$8.61M 0.04% 376
2023
Q1 		$5.31M Sell
37,542
-12,865
-26% -$1.84M 0.01% 575
2022
Q4 		$7.88M Sell
50,407
-2,573
-5% -$370K 0.02% 483
2022
Q3 		$6.5M Buy
52,980
+430
+0.8% +$56.6K 0.02% 510
2022
Q2 		$6.99M Sell
52,550
-84,454
-62% -$11.5M 0.02% 516
2022
Q1 		$18.7M Buy
137,004
+81,806
+148% +$11.4M 0.05% 325
2021
Q4 		$9.55M Buy
55,198
+1,045
+2% +$159K 0.02% 448
2021
Q3 		$7.87M Buy
54,153
+1,636
+3% +$239K 0.02% 479
2021
Q2 		$6.93M Sell
52,517
-3,051
-5% -$399K 0.02% 503
2021
Q1 		$7.13M Sell
55,568
-729
-1% -$89.8K 0.02% 482
2020
Q4 		$6.71M Sell
56,297
-14,806
-21% -$1.8M 0.02% 466
2020
Q3 		$8.14M Buy
71,103
+3,020
+4% +$357K 0.03% 396
2020
Q2 		$7.76M Sell
68,083
-111,443
-62% -$11.8M 0.03% 383
2020
Q1 		$14.4M Buy
179,526
+17,004
+10% +$1.76M 0.07% 271
2019
Q4 		$17.4M Buy
162,522
+28,612
+21% +$2.98M 0.06% 280
2019
Q3 		$14.3M Buy
133,910
+62,346
+87% +$6.4M 0.06% 294
2019
Q2 		$7.29M Sell
71,564
-54,484
-43% -$5.24M 0.03% 421
2019
Q1 		$11.3M Buy
126,048
+89,537
+245% +$7.76M 0.07% 300
2018
Q4 		$3.04M Buy
36,511
+30,331
+491% +$2.84M 0.02% 521
2018
Q3 		$670K Buy
6,180
+112
+2% +$12.3K ﹤0.01% 958
2018
Q2 		$667K Sell
6,068
-3,118
-34% -$325K ﹤0.01% 935
2018
Q1 		$921K Buy
9,186
+4,454
+94% +$456K 0.01% 847
2017
Q4 		$466K Buy
4,732
+1,760
+59% +$167K ﹤0.01% 1035
2017
Q3 		$278K Sell
2,972
-18
-0.6% -$1.91K ﹤0.01% 1118
2017
Q2 		$332K Sell
2,990
-132
-4% -$14K ﹤0.01% 1065
2017
Q1 		$307K Buy
3,122
+125
+4% +$11.9K ﹤0.01% 1070
2016
Q4 		$275K Sell
2,997
-146
-5% -$12.6K ﹤0.01% 1065
2016
Q3 		$266K Sell
3,143
-128
-4% -$10.8K ﹤0.01% 1084
2016
Q2 		$267K Buy
3,271
+40
+1% +$3.05K ﹤0.01% 1070
2016
Q1 		$231K Sell
3,231
-697
-18% -$46.7K ﹤0.01% 1115
2015
Q4 		$279K Buy
3,928
+140
+4% +$9.41K ﹤0.01% 1090
2015
Q3 		$233K Buy
+3,788
New +$265K ﹤0.01% 1119

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Baird Financial Group's DGX Position: Q1 2026 in Review

Baird Financial Group reduced its Quest Diagnostics (DGX) stake by 0.38% in Q1 2026, selling an estimated $12K and leaving 16,328 shares worth $3.2M. The position accounts for 0.01% of the portfolio, ranked #888.

Baird Financial Group first reported a position in DGX in Q3 2015 and has held it in 43 quarters since. The position peaked at $18.7M in Q1 2022. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Baird Financial Group held 16,328 shares of Quest Diagnostics worth $3.2M as of Q1 2026.
  • Baird Financial Group sold 62 Quest Diagnostics shares in Q1 2026, an estimated $12K.
  • Quest Diagnostics made up 0.01% of Baird Financial Group's portfolio in Q1 2026, its #888 holding.
  • Baird Financial Group first reported a position in Quest Diagnostics in Q3 2015 and has held it in 43 quarters since.
  • Baird Financial Group's Quest Diagnostics position peaked at $18.7M in Q1 2022.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.